Fletcher/CSI

(802) 660-9636

Pharma CI EUR Conference

By popular demand, the world's largest pharmaceutical competitive intelligence conference is holding its first European event in Zurich on February 21-22, 2012. Fletcher/CSI Healthcare Strategies has been the main sponsor of the Pharma CI USA Conference for 10 years, and now we are excited to be sponsoring the European conference as well.

Pharma CI Conference Europe 2012

SCIP 2012: Philadelphia, PA

SCIP (Strategic and Competitive Intelligence Professionals) summits are excellent ways to update your CI skills and knowledge, while networking with peers, colleagues, and gurus from all over the world. It is a vital event for competitive and strategic planning professionals. The conference sessions are highly informative and the networking opportunities are incomparable. SCIP attendees inevitably come away with useful frameworks that they take back to their organizations to build upon for the coming year

As a leading sponsor of the event, we welcome the opportunity to network with participants and to learn more about your competitive challenges. The Fletcher/CSI session discussed unique and robust competitive intelligence methodology and tools that can help you gain sustainable market advantage, anticipate emerging mega trends, and develop winning value propositions.

We hope to see you in Philadelphia this May. Please visit the conference website for more information.

Recap: Pharma CI 2011

The 10th annual Pharmaceutical CI Conference was held in New Jersey on September 13 and 14 was a resounding success. Originally started by Fletcher/CSI, the event has grown into the must attend event for pharmaceutical company professionals and our colleagues in the consulting industry.

Attendees shared experiences and techniques for collection, analysis, and implementation of competitive intelligence as well as forward-looking perspectives on the pharmaceutical and medical device markets. Fletcher/CSI thought leaders addressed participants on a diverse range of topics such as a comparison between U.S. and European healthcare systems, the state of technology tools for CI collection in the Pharmaceutical and medical device markets, the future of biosimilars in the market, and the use of adjacent markets to identify competitive advantage.